UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Nature communications, 2019-06, Vol.10 (1), p.2816-11, Article 2816

2019

Link zum Volltext

Verfügbarkeit prüfen

Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate

Journal of medicinal chemistry, 2017-07, Vol.60 (13), p.5889-5908

2017

Link zum Volltext

Verfügbarkeit prüfen

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2129-2132

2009

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structures of the Human and Fungal Cytosolic Leucyl-tRNA Synthetase Editing Domains: A Structural Basis for the Rational Design of Antifungal Benzoxaboroles

Journal of molecular biology, 2009-07, Vol.390 (2), p.196-207

2009

Link zum Volltext

Verfügbarkeit prüfen

Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation

mBio, 2020-01, Vol.11 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Journal of medicinal chemistry, 2017-10, Vol.60 (19), p.8011-8026

2017

Link zum Volltext

Verfügbarkeit prüfen

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

FEBS letters, 2012-09, Vol.586 (19), p.3410-3414

2012

Link zum Volltext

Verfügbarkeit prüfen

Boron-based drugs as antiprotozoals

Current opinion in infectious diseases, 2011-12, Vol.24 (6), p.586-592

2011

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1394-1403

2013

Link zum Volltext

Verfügbarkeit prüfen

Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6‑(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles

Journal of medicinal chemistry, 2015-07, Vol.58 (13), p.5344-5354

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Penetration of a Novel Oxaborole Antifungal (AN2690) Into the Human Nail Plate

Journal of pharmaceutical sciences, 2007-10, Vol.96 (10), p.2622-2631

2007

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents

Bioorganic & medicinal chemistry letters, 2011-01, Vol.21 (2), p.644-651

2011

Link zum Volltext

Verfügbarkeit prüfen

Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles

Bioorganic & medicinal chemistry letters, 2012-02, Vol.22 (3), p.1299-1307

2012

Link zum Volltext

Verfügbarkeit prüfen

Structure–activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent

Bioorganic & medicinal chemistry letters, 2013-03, Vol.23 (6), p.1680-1683

2013

Link zum Volltext

Verfügbarkeit prüfen

Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis

Future medicinal chemistry, 2011-08, Vol.3 (10), p.1259-1278

2011

Link zum Volltext

Verfügbarkeit prüfen

Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2270-2274

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases

Bioorganic & medicinal chemistry letters, 2006-12, Vol.16 (23), p.5963-5967

2006

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease

Bioorganic & medicinal chemistry letters, 2012-04, Vol.22 (8), p.2993-2996

2012

Link zum Volltext

Verfügbarkeit prüfen

Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus

Virology (New York, N.Y.), 1998-10, Vol.250 (2), p.255-262

1998

Link zum Volltext

Verfügbarkeit prüfen

Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships

Bioorganic & medicinal chemistry letters, 2002-11, Vol.12 (21), p.3101-3103

2002

Link zum Volltext

Verfügbarkeit prüfen

Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (10), p.2643-2645

2004

Link zum Volltext

Verfügbarkeit prüfen

Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability

Journal of medicinal chemistry, 1988-12, Vol.31 (12), p.2277-2288

1988

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and antitumor activity of structural analogs of the epipodophyllotoxins

Journal of medicinal chemistry, 1991-03, Vol.34 (3), p.984-992

1991

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and structure-activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir)

Bioorganic & medicinal chemistry letters, 2002-04, Vol.12 (8), p.1185-1187

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Pharmacology & Pharmacy
(31)
Chemistry, Medicinal
(28)
Structure-Activity Relationship
(27)
Animals
(24)
Chemistry
(22)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Pharmacology. Drug Treatments
(17)
Boron Compounds - Chemistry
(13)
Mice
(13)
Physical Sciences
(13)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)
Chemistry, Organic
(12)
Renin - Antagonists & Inhibitors
(11)
Exact Sciences And Technology
(10)
Molecular Structure
(10)
Organic Chemistry
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

Crystal Structures of the Human and Fungal Cytosolic Leucyl-tRNA Synthetase Editing Domains: A Structural Basis for the Rational Design of Antifungal Benzoxaboroles

Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

Boron-based drugs as antiprotozoals

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6‑(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles

In Vitro Penetration of a Novel Oxaborole Antifungal (AN2690) Into the Human Nail Plate

Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents

Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles

Structure–activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent

Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis

Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application

Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases

Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease

Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus

Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships

Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships

Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability

Synthesis and antitumor activity of structural analogs of the epipodophyllotoxins

Synthesis and structure-activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir)

Aktive Filter

Suchergebnisse filtern